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P2X2 receptors are ATP-gated ion channels widely expressed by neurons. Thr
339 lies in the second of the two transmembrane domains of
the rat P2X2 receptor protein, and is likely to be close to the narrowest part of the pore. Single-channel and whole-cell recording after
expression in human embryonic kidney 293 cells showed that P2X2[T339S] receptors had pronounced spontaneous channel openings
that were never seen in wild-type P2X2 receptors. P2X2[T339S] receptors were 10-fold more sensitive than wild type to exogenous ATP,
and meATP also increased channel opening. Two conserved ectodomain lysine residues (Lys69 and Lys308) are critical for function
andhavebeenproposed to contribute to theATPbinding site ofP2Xreceptors. The spontaneousopeningofP2X2[K69A/T339S] receptors
was not different than that seen in P2X2[T339S], but for P2X2[K308A/T339S] the spontaneous activity was absent. Suramin, which is a
noncompetitive antagonist at wild-type P2X2 receptors, had a pronounced agonist action at both P2X2[T339S] and P2X2[K69A/T339S]
receptors but not at P2X2[K308A/T339S]. 2,3-O-O-(2,4,6-Trinitrophenyl)-ATP (TNP-ATP), which is a competitive agonist at wild-type
receptors, was also an agonist at P2X2[T339S] receptors, but not at either double mutant. The results indicate that the T339S mutation
substantially destabilizes the closed channel and suggest an important role in channel gating. The correction of this gating defect, in the
absence of any agonist, by the secondmutation K308A shows that Lys308 is also involved in channel gating. A similar interpretation can
account for the results with suramin and TNP-ATP.
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Introduction
P2X receptors are membrane ion channels that serve as one class
of receptor for extracellular ATP. In the nervous system, they
have been ascribed roles in neuronal synaptic transmission and
itsmodulation (North andVerkhratsky, 2006; Sim et al., 2006) as
well as in the function of microglia (Tsuda et al., 2005). The P2X2
receptor is widely expressed in nervous tissue, and experiments
using P2X2 knock-out mice show functional roles at the presyn-
aptic side of excitatory synapses on to stratum radiatum inter-
neurons (Khakh et al., 2003), the postsynaptic aspect of synapses
on some myenteric plexus neurons (Ren et al., 2003), and on
primary afferent nerves in taste buds (Finger et al., 2005), blad-
der, and other sites (Cockayne et al., 2005).
P2X receptors assemble and function as trimers. The individ-
ual subunits appear to have internal N and C termini, two
membrane-spanning (TM) segments, and an extracellular do-
main of 280 aa (North, 2002). There has been considerable
progress in understanding themolecular operation of P2X recep-
tors, mostly thus far by inferences from biophysical experiments
on expressed receptors that contain engineered mutations. Such
experimental approaches have indicated, for example, that parts
of the TM domains contribute to the permeation pathway, and
that residues around Thr339, Ser340, and Gly342 in TM2 are near
the narrowest part of the pore (Migita et al., 2001; Egan and
Khakh, 2004; Egan et al., 2006). They also indicate that the outer
ends of the TMs (Val48 and Ile328) of different subunits move
relative to each other when the channel opens (Jiang et al., 2001).
Mutagenesis in the extracellular domain of the receptor has
drawn attention to the role of two conserved lysine residues
(Lys69 and Lys308 in rat P2X2 receptors). It has been suggested
that the positive charges provided by these residues might inter-
act with the negatively charged phosphate moiety of the ATP
molecule (Ennion et al., 2000; Jiang et al., 2000; Roberts et al.,
2006;Wilkinson et al., 2006; Yan et al., 2006).However, attractive
as such an interpretationsmay be, it is not possible on the basis of
measurements of macroscopic channel activity to distinguish be-
tween a primary alteration in agonist binding and a change in the
mechanism by which a liganded closed channel undergoes the
conformational change into an open channel (Colquhoun, 1998,
2006).
One way to distinguish binding from gating is to eliminate the
binding step altogether: that is, to study spontaneous openings of
the channel in the absence of any agonist. In the present ap-
proach, we have used a P2X2 receptor that differs from wild type
only by the removal of amethyl group at Thr339 (i.e., side chain is
–CH2OH instead of –CH(OH)CH3). These P2X2[T339S] chan-
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nels showed spontaneous channel openings. They could also be
opened by suramin and by 2,3-O-(2,4,6-trinitrophenyl)-ATP
(TNP-ATP), which are antagonists at wild-type P2X receptors.
By studying the combined effects of the T339S substitution with
changes to the lysines, we conclude that Lys308 plays a key role in
channel gating.
Materials andMethods
Molecular and cell biology.Mutations in rat P2X2 receptors were made as
described previously (Rassendren et al., 1998; Jiang et al., 2000, 2001).
The wild-type and mutant P2X2 subunits were transiently coexpressed
together with GFP vector in HEK293 cells (by Lipofectamine 2000; In-
vitrogen, San Diego, CA), using 0.1 and 1 g per transfection, respec-
tively. Transfected cells were seeded on glass coverslips coated with
poly-L-lysine.
Western blot and surface expression. Cell surface protein was labeled
using EZ-link sulfo-NHS-LC-biotin (Pierce, Cramlington, UK). Conflu-
ent cells (one 35mm culture dish per sample) were washed three times in
PBS, pH 8.0, and incubated in 1 ml of PBS containing 0.5 mg/ml biotin
for 30 min at 4°C. After washing, cells were centrifuged, and pellets lysed
in PBS containing 2% Triton X-100 and antiproteases (complete EDTA;
Roche, Lewes, UK) for 1 h at 4°C. After centrifugation (16,000  g; 2
min) to remove debris, total protein samples were removed and assayed
for protein content using a protein assay kit (Bio-Rad, Hemel Hemp-
stead, UK). Biotinylated surface protein in the cell lysate was bound to
immuno-pure immobilized streptavidin beads (Pierce) overnight at 4°C.
After washing in 0.2% Triton X-100, SDS-PAGE sample buffer was
added and the samples were boiled (5 min; 100°C) to release cell surface
protein. Samples were separated on 4–12% Nu-PAGE gels (Invitrogen)
and transferred to PVDF membranes. Western blotting was performed
according to standard protocols and proteins were visualized using anti-
EYMPME primary antibody (Universal Biologicals, Cambridge, UK)
and HRP-conjugated secondary antibody (both at 1:5000 dilution), fol-
lowed by detection using the ECL-plus kit (Amersham Biosciences,
Buckinghamshire, UK) andKodak BioMaxMS film. Band densities were
quantified using GeneSnap/GeneTools software (Syngene, Frederick,
MD), and densities were compared using analysis of variance.
Electrophysiological recording. Recordings were made at room temper-
ature 24–72 h after transfection, using outside-out and whole-cell con-
figurations of the patch-clamp technique (Hamill et al., 1981). For
single-channel recording, coverslips were removed from the recording
chamber after the outside-out configuration was obtained. Recording
pipettes were pulled from borosilicate glass (World Precision Instru-
ments, Stevenage, UK) and had resistances of 10–20 M for single-
channel recording and 2–4 M for whole-cell recording. The usual
holding potential was 60 mV for whole-cell and 100 mV for single-
channel recording. The extracellular solution contained the following (in
mM): 147 NaCl, 2 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, and 13 glucose.
When a high concentration of Na2ATP was used, the pH was carefully
corrected with NaOH and the NaCl content was adjusted to maintain its
normal value. The intracellular (pipette) solution comprised the follow-
ing (in mM): 147 NaF, 10 HEPES, and 10 EGTA. All solutions were
maintained at pH 7.3 and 300–315mOsm/L. Chemicals were purchased
from Sigma (Poole, UK).
Currents were recorded with a patch-clamp amplifier (Axopatch
200B) using pClamp 9 software (Molecular Devices, Palo Alto, CA). The
data were low-pass filtered at 3 kHz with an eight-bessel filter (LHBF-
48X; NPI, Tamm, Germany) and digitized at 10 kHz (single channel) or
2 kHz (whole cell). We generated dose–response curves for ATP and
other compounds by applying these drugs through an RSC200 rapid
perfusion system (Biologic, Claix, France). Agonists were applied for 2 s
or, in the case of lower concentrations, until a steady-state current was
recorded. Current–voltage relationshipswere obtained from the currents
measured during a linear voltage ramp, which consisted of one step to
150mVand a 400ms linear voltage ramp to100mV; this was applied
every 1 s from a holding potential of60 mV.
Data analysis. Electrophysiological measurement data were analyzed
using Clampfit 9 software (Molecular Devices) and Prism 4.0 (GraphPad
Software, San Diego, CA). Pooled data are given as the mean  SEM.
Tests for statistical significance were performed using nonparametric
ANOVA. Concentration–response curves for individual cells were fit to
I Imax/[1 (EC50/[A])
n], where I is the current, and [A] is the agonist
concentration. The fit was used to estimate the maximum response
(Imax), the concentration of agonist needed to evoke a half-maximal
response (EC50), and the Hill slope (n). The change in free energy (in
joules per mole) required to open the channel (	(	G)) was calculated
from the differences in pEC50 values of mutant and wild-type receptors,
using (	(	G))RT ln(EC50,mut/EC50,wt), where R is the molar gas
constant, T is the temperature (in degrees kelvin), and EC50,mut and
EC50,wt are the half-maximal ATP concentrations for the mutant and
wild-type receptors, respectively (Maksay et al., 1999; Mo¨ttig et al., 2001;
Li et al., 2004).
Results
Spontaneous channel openings in P2X2[T339S]
Outside-out patch recordings from cells expressing wild-type rat
P2X2 receptors showed no activity in the absence of applied ago-
nist (up to 30 min) (Fig. 1A). ATP (1–30 M) evoked discrete
inward currents with unitary conductance of 19.1 0.5 pS (n
22; measured at100 mV) (Fig. 1B). Patches from cells express-
ing P2X2[T339S] receptors showedmarked spontaneous channel
activity (Fig. 1C). The unitary conductance of the spontaneously
opening channels was 18.4 0.6 pS (n 6), which is not differ-
ent from the value for wild-type channels in the presence of ATP
( p
 0.05) (Fig. 1E,F).Weobserved similar spontaneous activity
in P2X2[T339G], but the unitary currents were of lower ampli-
tude (12.9 0.8 pS; n 9; p 0.001).
Many cells release ATP, andwewere concerned that the spon-
taneous activity observed in P2X2[T339S] receptors might result
from trace amounts of ATP present in the external solution. For
example, HEK293 cells expressing P2X1/5 heteromeric receptors
have a standing inward current (up to 50 pA) that results from the
release of ATP from the same or neighboring cells (Surprenant et
al., 2000). We incubated the cells expressing P2X2[T339S] recep-
tors with apyrase (4 U/ml; 1 h) and we included apyrase (10
U/ml) in the perfusion solution for up to 30 min. Neither treat-
ment altered the spontaneous activity that we observed (Fig. 1D).
In most experiments, we removed all the other cells by taking the
coverslips from the recording chamber after we had established
the outside-out configuration. This would effectively remove all
possible sources of extracellular ATP. This also did not alter the
spontaneous activity.
The spontaneous channel activity was also apparent at the
whole-cell level: cells expressing P2X2[T339S] receptors showed a
large inwardly rectifying current (Fig. 2B) that was absent from
cells expressing wild-type receptors.We quantified the difference
in the whole cell currents by measuring inward current at100
mV, from the voltage ramps (see Materials and Methods) (Fig.
2B,C). The values were as follows: wild type, 2.2  0.2 pA/pF
(n 33); T339S, 23.7 5.2 (n 26); andT339G, 17.9 7.4 (n
8). Spontaneous openings were not observed with T339C or
T339A receptors.
Application of ATP further increased the channel activity in
P2X2[T339S] and P2X2[T339G] receptors, without changing the
unitary conductance of the elementary channel openings. The
peak whole-cell currents evoked by ATP (10–100 M; pA/pF; at
60 mV) for wild-type, P2X2[T339S] and P2X2[T339G] recep-
tors were 172 19 (n 18), 194 31 (n 7), and 222 62 (n
8), suggesting that the point mutation had resulted in a channel
that was open 10% relative to that evoked by a maximal con-
centration of ATP. The concentration–response curve for ATP as
an agonist at the P2X2[T339S] and P2X2[T339G] receptors was
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shifted 10-fold to the left when com-
pared with parallel experiments on wild-
type receptors (Fig. 3A). From the ratio of
the pEC50 values, the value of 	(	G) be-
tween wild type and P2X2[T339S] was
2.33RT J/mol.
P2X2[T339S] receptors were also more
sensitive to meATP, which is a very
weak partial agonist at wild-type P2X2 re-
ceptors (Fig. 3A). The EC50 for wild-type
receptors was 400 M, whereas it was
only 50 M for P2X2[T339S]. For
meATP, the value of 	(	G) between
wild-type and P2X2[T339S] receptors was
2.15RT J/mol. This indicates that the dif-
ference in free energy for channel activa-
tion introduced by the T339S mutation is
independent of agonist.
Effect of Lys69 and Lys308 mutations on
spontaneous activity in P2X2[T339S]
Lys69 has been implicated in ATP binding
to P2X receptors (Jiang et al., 2001; Rob-
erts and Evans, 2004). Outside-out patch
recording showed that spontaneous chan-
nel activity in P2X2[K69A/T339S] was not
different from that observed in
P2X2[T339S] (Fig. 2A). Basal whole-cell
currents at 100 mV in P2X2[K69A/
T339S] were 14.8  2.3 pA/pF (n  19).
These findings further support the view
that spontaneous channel activity was not
attributable to the activation by trace ATP,
in the sense that the removal of a probable
ATP binding site does not alter the basal
channel activity. We confirmed previous
findings that P2X2[K69A] was essentially
insensitive to ATP (Fig. 3B). Cells trans-
fected with P2X2 subunits carrying both
mutations [K69A/T339S] provided sub-
stantial currents in response to ATP, al-
though the concentration response curve
was shifted10,000 times rightward rela-
tive to that for P2X2[T339S] (Fig. 3B).
The results for Lys308 were very differ-
ent. In this case, we observed that cells ex-
pressing the double mutation [K308A/
T339] showed very little spontaneous
activity in outside-out patches (Fig. 2A).
Whole-cell recordings gave basal currents
for P2X2[K308A/T339S] of 2.7  0.3
pA/pF (n  13) (Fig. 2C), which was not
different from wild type ( p 
 0.05). Sub-
stitution of Lys308 by cysteine gave a simi-
lar result as K308A: spontaneous activity was not observed (2.5
0.4 pA/pF; n 14; p
 0.05). We tested whether modification of
the cysteine side chain by methanethiosulfonate ethyltrimethyl-
ammonium (MTSET)would rescue the spontaneous channel ac-
tivity seen in the wild-type channel; however, in cells expressing
P2X2[K308C/T339S] receptors, there were only very rare spon-
taneous channel openings, and these were not changed by appli-
cation of MTSET (1 mM; 10 min). Application of ATP to cells
transfected with P2X2[K308A] receptors evoked no current, in
confirmation of the study by Jiang et al. (2001) (Fig. 3C). ATP
also did not activate any current at P2X2[K308A/T339S] recep-
tors (Fig. 3C).
We tested whether the positive charge of arginine might sub-
stitute for lysine in the context of blocking the spontaneous ac-
tivity introduced by the P2X2[T339S] mutation. Figure 2 shows
that P2X2[K308R/T339S] channels also exhibited considerable
spontaneous channel activity, with unitary events similar in am-
plitude to that observed in P2X2[T339S]. Basal whole-cell cur-
Figure 1. P2X2[T339S] receptors are spontaneously active. A, No spontaneous openings are observed in outside-out patches
from cells expressing wild-type receptor. B, ATP (1 M) activates single channels in outside-out patch from cell expressing
wild-type P2X2 receptors. C, P2X2[T339S] receptors show spontaneous opening in the absence of applied ATP. D, Spontaneous
activity in P2X2[T339S]was still observed after prolonged treatment in apyrase. Left, Cells had been incubated in apyrase (4 U/ml;
60 min). Right, After additional application of apyrase (10 U/ml; 30 min) to perfusing solution during outside-out recording. All
recordswere low-pass filtered at 3 kHz anddigitized at 10 kHz: holding potential,100mV. E, All-points histogram forwild-type
receptors activated by ATP (1M). F, All-points histogram for P2X2[T339S] receptors with no added ATP.
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rents were 7.4 3.2 pA/pF (n 19). This indicates that arginine
can only partially substitute for lysine in the context of maintain-
ing the spontaneous activity seen with the [T339S] mutation.
As shown by Jiang et al. (2001), we found that currents could be
evoked by ATP at P2X2[K308R] receptors but the effective ATP
concentrations were very much increased (Fig. 3C). However,
P2X2[K308R/T339S] receptors were more sensitive to ATP than
P2X2[K308R], with an EC50 of 100 M
(Fig. 3). The difference in free energy associ-
ated with the K308Rmutation was the same
whether in a wild type (2.33 RT J/mol) or
[T339S] background (2.38 RT J/mol).
Likewise, the difference in free energy asso-
ciatedwith theT339Smutationwas the same
whether in wild type (4.04 RT J/mol) or
[K308R] background (4.00 RT J/mol).
These results suggest that the substitutions at
the two positions Lys308 and Thr339 may
each inhibit gating by independent
mechanisms.
The expression at the plasma mem-
brane of the mutated receptors was not
different from that of the wild-type P2X2
receptor ( p 
 0.05). The relative cell sur-
face expression ratios determined by
Western blot and densitometry were as
follows: wild type, 0.94  0.1 (n  14);
[T339S], 1.2  0.6 (n  4); [K69A],
1.0 0.19 (n 4); [K69A/T339S], 1.1
0.11 (n 4); [K308A], 0.84 0.23 (n
5); [K308A/T339S], 0.50 0.15 (n 4);
[K308C/T339S], 1.0 0.06 (n 3); and
[K308R/T339S], 0.96  0.14 (n  4). In
view of this evidence that there are not
marked differences among various mu-
tated receptors in terms of expression at
the plasma membrane, we may seek to
interpret the absolute values of the cur-
rents evoked by ATP. In the original
studies on Lys 69 and Lys 308, it was found
that substitution of either lysine by ala-
nine produced a channel that was insen-
sitive to ATP up to 3 mM (Jiang et al.,
2000). The increased sensitivity to ATP
that we find in the [T339S] mutant al-
lows the effect of each of the lysine-to-
alanine substitutions to be examined
more closely, and this showed a qualita-
tive difference between their contribu-
tions. In the background of the T339S
substitution, the substitution [K308R]
caused a clear reduction in the maxi-
mum current (Fig. 3C), whereas the ef-
fect of removing Lys 69 (in K69A) was
more consistent with a rightward shift in
the ATP concentration–response curve.
As Colquhoun (1998) has pointed out, a
primary change in a binding site might
be expected to cause a right-shift in ago-
nist concentration–response curve,
whereas a primary effect at a subsequent
step (such as gating) would be expected
to reduce the maximal response.
Partial agonist actions of suramin and TNP-ATP at
P2X2[T339S]
Suramin is an antagonist at most P2X receptors (Khakh et al.,
2001), including rat P2X2 (Brake et al., 1994; Evans et al., 1995).
However, we found that suramin strongly increased channel ac-
tivity when applied to P2X2[T339S] receptors (Fig. 4A,B) (also
Figure 2. Spontaneous channel activity in P2X2[T339S] does not require Lys
69 but does require Lys 308. A, Outside-out record-
ing shows that spontaneous channel opening persists when Lys 69 is mutated ([K69A/T339S]), but not when Lys 308 is mutated
([K308A/T339S], [K308C/T339S]): holding potential,100 mV. [K308R/T339S] gives limited spontaneous activity. B, Current–
voltage plots for whole-cell currents in typical cells expressing the point mutations indicated, in the absence of ATP. C, Summary
data for spontaneous inward current (100 mV) recorded in the eight groups of cells indicated (n 9–33). D, Schematic to
illustrate relative positions of Lys 69, Lys 308, and Thr 339.
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P2X2[T339G]) (data not shown): it had no
such agonist activity at wild-type receptors
in concentrations up to 1 mM (Fig. 4D).
The unitary conductance of channels acti-
vated by suramin (18  1 pS; n  6; p 

0.05) was not different from that which
occurred spontaneously. At the whole-cell
level, the suramin EC50 for P2X2[T339S]
was 100 M (Fig. 4B) (150 M for
P2X2[T339G]) (data not shown). The cur-
rent–voltage relationship for the suramin-
activated currents was not strikingly dif-
ferent from that for ATP-activated
currents at wild-type receptors (Fig. 4C),
although the maximal current amplitudes
were approximately one-fifth of those ac-
tivated by ATP (100M) (Fig. 5). Suramin
retained its activity to block ATP-evoked
currents in P2X2[T339S] receptors (Fig.
4D). The IC50 was10M, similar to that
observed for wild-type receptors (Fig.
4D), and to the values previously reported
for rat P2X2 receptors (Evans et al., 1995).
These results indicate that suramin is a
partial agonist at P2X2[T339S] receptors.
A similar agonist action of suramin was
observed in P2X2[K69A/T339S] (Fig. 5A).
These data are consistent with suramin
binding to a site distinct from that of ATP,
in agreement with other studies suggesting
that suramin does not act as a competitive
antagonist (Evans et al., 1995; Trujillo et
al., 2006). In contrast, mutation of Lys308
(i.e., P2X2[K308A/T339S]) resulted in the loss of the agonist ac-
tion of suramin. This is consistent with Lys308 playing a key role
in gating, independent of the agonist used to open the channel.
TNP-ATP is a competitive antagonist at P2X receptors, with a
1000-fold selectivity for P2X1, P2X3, P2X2/3 receptors relative to
others (Virginio et al., 1998; Khakh et al., 2001). We found that
TNP-ATP activated P2X2[T339] receptors (Fig. 5B). This agonist
action required a very high concentration (EC50,200 M), but
wild-type P2X2 receptors were not activated by such concentra-
tions of TNP-ATP (up to 3 mM). In both the double mutants
P2X2[K69A/T339S] and P2X2[K308A/T339S], TNP-ATP lost its
agonist action (Fig. 5B). If TNP-ATP binds to the same site(s) as
ATP, as is suggested for the homomeric P2X3 receptor (Burgard
et al., 2000) and for the homomeric P2X2 receptor (Trujillo et al.,
2006), then these results indicate that Lys69 is involved in agonist
binding. PPADS (pyridoxalphosphate-6-azophenyl-2,4-
disulfonic acid) (3 mM; 5 min application) had no discernible
agonist action at P2X2[T339S] receptors.
Discussion
This is the first report of single-channel recordings in conjunc-
tion with mutations in a P2X receptor. We found that replace-
ment of Thr339 by either serine or glycine produced a channel
with considerable spontaneous activity. However, replacement
by alanine or cysteine did not result in significant spontaneous
channel opening. This suggests that this part of the protein is
critically involved in the molecular rearrangements of channel
gating, but it does not yet allow a simple interpretation in terms of
the precise side-chain requirements. In any event, the Thr residue
at position 339 of the rat P2X2 receptor is not completely con-
served among P2X subunits [in mammalian sequences, it is Gly
in P2X1; Ala in P2X4, P2X5, and P2X6; Ser in P2X7; and Thr in
P2X2 and P2X3; and in the protist Dictyostelium discoideum se-
quence, it is Gly (Fountain et al., 2007)]. Therefore, the atomic
detail of the change introduced by [T339S] is quite subunit spe-
cific. Previous mutagenesis experiments on rat P2X2 receptors in
whichwhole-cell currents weremeasured indicate that Cys (Egan
et al., 1998; Rassendren et al., 1998) and Ala (Li et al., 2004) are
well tolerated at this position in the rat P2X2 receptor (Egan et al.,
1998; Rassendren et al., 1998), although replacement of Thr339 by
Ala was reported to slightly increase ATP sensitivity (Li et al.,
2004). In rat P2X4 receptors, the substitution of the equivalent
Ala344 by Trp renders the channel 30-fold more sensitive to
ATP (Silberberg et al., 2005).
The destabilization of a closed state of the channel that occurs
with the [T339S] substitution allows one also to study the agonist
actions of meATP. This ATP analog is generally considered to
be without agonist action at homomeric P2X2 receptors, and it is
therefore a valuable tool in distinguishing P2X1 receptors, and
P2X3 subunit-containing receptors (Lewis et al., 1995; North,
2002). Wild-type P2X2 receptors are indeed activated by
meATP, but only at concentrations exceeding 30–100 M
(Wilkinson et al., 2006).Other pointmutations been described in
P2X2 receptors that result in an increased sensitivity tomeATP
(e.g., Phe44 in the first TM of P2X2 receptors) (Jiang et al., 2001).
We note that Phe44 and Thr339 are situated at approximately the
same relative distance through the membrane in most models of
the P2X receptor (North, 2002) and could both contribute to a
channel gate.
A role in permeation for Thr339 comes from the work by Egan
Figure 3. Agonist-activated currents in P2X2[T339S] alone and in combination with substitutions at Lys
69 and Lys 308. A, ATP
(left) and meATP (right) concentration–response curves for cells expressing wild-type or P2X2[T339S] receptors. B, ATP
concentration–response curves for double mutations [K69A/T339S] and [K69A] alone. The broken lines show same data as in A.
C, ATP concentration–response curves for double mutations [K308A/T339S] and [K308A] alone, and for double mutations
[K308R/T339S] and for [K308R] alone. The broken lines show same data as in A. Peak currents were measured at60 mV.
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and Khakh (2004). They measured both membrane currents and
the change in intracellular calcium concentration, and were thus
able to calculate the fraction of the inward current carried by
calcium. They found that the introduction of amino acids with
larger side chains (Val, Tyr) at this position led to a marked
reduction in the permeability of calcium relative to sodium ions.
They concluded that this residue therefore lies close to the selec-
tivity filter of the channel.
An important consideration of the presentworkwas to use the
spontaneous activity of the mutant P2X receptor channel to dis-
tinguish inferences regarding the effects of mutations on agonist
binding or on channel gating (Colquhoun, 1998, 2006). How-
ever, one must expect that a wide range of mutations could de-
stabilize a channel protein so as to produce spontaneous activity.
Thus, several ligand-gated channels have been reported to open
spontaneously when (relatively minor)
mutations have been introduced into their
structure. Some examples for homomeric
channels are GABA  receptors (Pan et al.,
1997; Torres and Weiss, 2002), glycine 1
receptors (Dupre et al., 2007), nicotinic7
receptors (Bertrand et al., 1997), and glu-
tamate 2 receptors (Zuo et al., 1997). The
approach is of course subject to the criti-
cism that the open state of the mutated
channel is surely not identical with that of
the liganded channel. It is for this reason
that we have focused in the present study
on the relatively striking change observed
with a rather minor side chain alteration
(Thr to Ser), at a position in the receptor at
which such an alteration is tolerated in
other closely homologous subunits.
With these caveats, we proceed to dis-
cuss the additional effect of mutating ei-
ther of the lysine residues previously in-
ferred to be involved in ATP binding.
Taking first Lys 69, we found no evidence
that the replacement of Lys 69 by Ala had
any effect on the spontaneous channel
activity introduced by T339S; that is,
there was no difference between [T339S]
and [K69A/T339S] in the degree of
spontaneous activity observed in the ab-
sence of agonist. It was difficult to mea-
sure accurately the relative change in ef-
fectiveness of applied ATP caused by the
substitution of T339S because of the very
weak response to ATP observed in
P2X2[K69A] channels (pEC50  1.5)
(Fig. 3B) (Jiang et al., 2000). This made it
impossible to estimate the 	(	G) asso-
ciated with the substitution of Ala for
Lys 69 in the wild-type channel. ATP did
have a clear agonist action at the [K69A/
T339S] channel (pEC50  2) (Fig. 3B),
which is consistent with the 10-fold left-
ward shift of the dose–response curve for
ATP that was observed when this substi-
tution was introduced alone into the
wild-type channel.
Whether Lys or Ala was present at po-
sition 69made no difference to the agonist
action of suramin that was observed in the P2X2[T339S] back-
ground. On the other hand, the nucleotide analog TNP-ATP lost
its agonist action at P2X2[T339S] when the additional [K69A]
mutation was introduced. These results are consistent with
suramin acting allosterically to open the P2X2 channel that has
been destabilized by the T339S substitution. They are in accord
with the interpretation that the competitive blocker TNP-ATP
likely shares key binding residues with ATP, including Lys69. A
simple conclusion from these results is that Lys69 does not play a
significant role in channel gating (at least for the [T339S] recep-
tor): the large effect of removing the lysine at this position re-
mains consistent with a direct involvement in agonist binding.
Turning next to Lys308, the most surprising finding was that
the double-mutant channel P2X2[K308A/T339S] did not show
Figure 4. Agonist actions of suramin.A, Outside-out patch recordings (left) and all-points histogram (right) from cell express-
ing P2X2[T339S] receptors: suramin concentration was 30 M. B, Whole-cell recordings show currents evoked by different
concentrations of suramin. C, Current–voltage relationship for current activated by suramin (100 M). D, Concentration–re-
sponse curve for suramin as agonist at P2X2[T339S] receptors (continuous line), and as an antagonist of ATP action at P2X2[T339S]
and wild-type receptors (broken line). ATP concentration was 5M for wild type and 1M for T339S.
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the spontaneous opening observed with P2X2[T339S]. In other
words, lysine at position 308 is required for the conformational
change associated with channel opening. If we proceed on the
assumption that the open state(s) observed with the T339S mu-
tation are essentially similar to those normally induced by ATP
(they have the same unitary conductance), then it follows that
Lys308 is critical for channel opening. With respect to this effect,
arginine can only partially substitute for lysine. The K308R sub-
stitution did not cause such a large shift in ATP potency as
K308A, and this allowed us to compare the change in free energy
associated with the introduction of the T339S in the wild-type
(2.33RT) and the K308R (2.38RT) channels. This similarity
suggests that eachmutation has an independent effect on channel
gating.
At the P2X2[T339S] receptor, suramin behaved as a partial
agonist. In the absence of ATP, suramin activated currents with
an EC50 of 100 M. The properties of the currents (unitary
conductance, current–voltage relationship) were not obviously
different from those evoked by ATP. Suramin also blocked the
effect of addedATPwith an IC50 of10M; this concentration is
similar to that required to block wild-type P2X2 receptors (Fig. 4)
(Evans et al., 1995). Removal of the lysine residue at position 69
did not alter the agonist action of suramin, consistent with its
action at an allosteric site, distinct from that used by ATP. Re-
moval of the lysine residue at position 308 did prevent the agonist
action of suramin. This would be consistent with Lys308 being
critical for channel opening in the P2X2[T339S] receptor (see
above), although a direct involvement of Lys308 in suramin bind-
ing cannot be excluded.
The interpretation of the experimental findings with TNP-
ATP are complicated by the need to use rather high concentra-
tions [at least, relative to those that block P2X1, P2X3, and P2X2/3
receptors (Virginio et al., 1998)]. However, the agonist action of
TNP-ATP at P2X2[T339S] receptors was completely lost when
either lysine residue was additionally mutated to alanine (Fig.
5B). Taken with the previous results, the simplest interpretation
of these findings is that TNP-ATP loses its agonist action in
P2X2[K69A/T339S] because Lys
69 is needed for binding, and it
loses its effect at P2X2[K308A/T339S] because the P2X receptor
cannot open without an intact Lys308.
The principal finding of the present work is that Lys308 is
similarly important for opening of the P2X2 receptor channel
whether this is driven by ATP binding or by a relatively minor
amino acid substitution within the second TM [T339S]. Al-
though this does not exclude a role for Lys308 in ATP binding, it
clearly implies a role in channel gating. The additional finding
that Lys308 is also important for the agonist action of suramin is
most consistent with a primary role in gating. These findings
refocus attention on the very highly conserved region of all P2X
receptors between Lys308 and the extracellular end of the second
TM domain (likely in the region of Ile328). This could imply that
this part of the receptor forms a crucial “linker” that transduces
binding in the ectodomain to movement of the transmembrane
regions (Yan et al., 2006). However, another simple model that
would position the lysine closer to the middle of the second TM
would be a reentrant loop of the kind that is found in potassium
channels, and that was initially proposed for P2X receptors when
their sequences were first disclosed (Brake et al., 1994; Valera et
al., 1994).
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